Jianfeng Xu

ORCID

Publication Activity (10 Years)

Years Active: 2017-2022
Publications (10 Years): 20

Top Venues

The Prostate

This page only lists publications with an associated author ORCID identifier.

Publications

Jun Wei, Jennifer Beebe-Dimmer, Zhuqing Shi, Christopher Sample, Guifang Yan, Andrew S Rifkin, Azita Sadeghpour, Marta Gielzak, Sodam Choi, David Moon, S Lilly Zheng, Brian T Helfand, Patrick C Walsh, Jianfeng Xu, Kathleen A Cooney, William B Isaacs
Association of rare, recurrent nonsynonymous variants in the germline of prostate cancer patients of African ancestry. The Prostate 83 (5) (2022)
Jun Wei, Jennifer Beebe-Dimmer, Zhuqing Shi, Christopher Sample, Guifang Yan, Andrew S Rifkin, Azita Sadeghpour, Marta Gielzak, Sodam Choi, David Moon, S Lilly Zheng, Brian T Helfand, Patrick C Walsh, Jianfeng Xu, Kathleen A Cooney, William B Isaacs
Association of rare, recurrent nonsynonymous variants in the germline of prostate cancer patients of African ancestry. The Prostate 83 (5) (2022)
Jun Wei, Jennifer Beebe-Dimmer, Zhuqing Shi, Christopher Sample, Guifang Yan, Andrew S Rifkin, Azita Sadeghpour, Marta Gielzak, Sodam Choi, David Moon, S Lilly Zheng, Brian T Helfand, Patrick C Walsh, Jianfeng Xu, Kathleen A Cooney, William B Isaacs
Association of rare, recurrent nonsynonymous variants in the germline of prostate cancer patients of African ancestry. The Prostate 83 (5) (2022)
Jun Wei, Jennifer Beebe-Dimmer, Zhuqing Shi, Christopher Sample, Guifang Yan, Andrew S Rifkin, Azita Sadeghpour, Marta Gielzak, Sodam Choi, David Moon, S Lilly Zheng, Brian T Helfand, Patrick C Walsh, Jianfeng Xu, Kathleen A Cooney, William B Isaacs
Association of rare, recurrent nonsynonymous variants in the germline of prostate cancer patients of African ancestry. The Prostate 83 (5) (2022)
Jun Wei, Jennifer Beebe-Dimmer, Zhuqing Shi, Christopher Sample, Guifang Yan, Andrew S Rifkin, Azita Sadeghpour, Marta Gielzak, Sodam Choi, David Moon, S Lilly Zheng, Brian T Helfand, Patrick C Walsh, Jianfeng Xu, Kathleen A Cooney, William B Isaacs
Association of rare, recurrent nonsynonymous variants in the germline of prostate cancer patients of African ancestry. The Prostate (2022)
Zhuqing Shi, Lucy Lu, William Kyle Resurreccion, Wancai Yang, Jun Wei, Qiang Wang, Valentina Engelmann, Siqun Lilly Zheng, Kathleen A Cooney, William B Isaacs, Brian T Helfand, Jim Lu, Jianfeng Xu
Association of germline rare pathogenic mutations in guideline-recommended genes with prostate cancer progression: A meta-analysis. The Prostate 82 (1) (2021)
Jun Wei, Wancai Yang, Zhuqing Shi, Lucy Lu, Qiang Wang, W Kyle Resurreccion, Valentina Engelmann, S Lilly Zheng, Peter J Hulick, Kathleen A Cooney, William B Isaacs, Brian T Helfand, Jim Lu, Jianfeng Xu
Observed evidence for guideline-recommended genes in predicting prostate cancer risk from a large population-based cohort. The Prostate 81 (13) (2021)
Jianfeng Xu, William B Isaacs, Mufaddal Mamawala, Zhuqing Shi, Patricia Landis, Jacqueline Petkewicz, Jun Wei, Chi-Hsiung Wang, W Kyle Resurreccion, Rong Na, Yasin Bhanji, Kristian Novakovic, Patrick C Walsh, S Lilly Zheng, Brian T Helfand, Christian P Pavlovich
Association of prostate cancer polygenic risk score with number and laterality of tumor cores in active surveillance patients. The Prostate 81 (10) (2021)
Wennuan Liu, Jun Hou, Jacqueline Petkewicz, Rong Na, Chi-Hsiung Wang, Jishan Sun, Johnie Gallagher, Yedida Y Bogachkov, Laura Swenson, MaryAnn Regner, W Kyle Resurreccion, William B Isaacs, Charles B Brendler, Susan Crawford, S Lilly Zheng, Brian T Helfand, Jianfeng Xu
Feasibility and performance of a novel probe panel to detect somatic DNA copy number alterations in clinical specimens for predicting prostate cancer progression. The Prostate 80 (14) (2020)
Yang Xu, Da Huang, Yishuo Wu, Dingwei Ye, Ning Zhang, Yi Gao, Danfeng Xu, Rong Na, Jianfeng Xu
Family history is significantly associated with prostate cancer and its early onset in Chinese population. The Prostate 79 (15) (2019)
Hongjie Yu, Zhuqing Shi, Yishuo Wu, Chi-Hsiung Wang, Xiaoling Lin, Chelsea Perschon, William B Isaacs, Brian T Helfand, S Lilly Zheng, David Duggan, Zengnan Mo, Daru Lu, Jianfeng Xu
Concept and benchmarks for assessing narrow-sense validity of genetic risk score values. The Prostate 79 (10) (2019)
Hongjie Yu, Zhuqing Shi, Xiaoling Lin, Quanwa Bao, Haifei Jia, Jun Wei, Brian T Helfand, Siqun L Zheng, David Duggan, Daru Lu, Zengnan Mo, Jianfeng Xu
Broad- and narrow-sense validity performance of three polygenic risk score methods for prostate cancer risk assessment. The Prostate 80 (1) (2019)
Brian T Helfand, Haitao Chen, Richard J Fantus, Carly A Conran, Charles B Brendler, Siquan Lilly Zheng, Patrick C Walsh, William B Isaacs, Jianfeng Xu
Differences in inherited risk among relatives of hereditary prostate cancer patients using genetic risk score. The Prostate (2018)
Yishuo Wu, Hongjie Yu, Siqun Lilly Zheng, Bingjian Feng, Ashley L Kapron, Rong Na, Julie L Boyle, Sameep Shah, Zhuqing Shi, Charles M Ewing, Kathleen E Wiley, Jun Luo, Patrick C Walsh, Herbert Ballentine Carter, Brian T Helfand, Kathleen A Cooney, Jianfeng Xu, William B Isaacs
Germline mutations in PPFIBP2 are associated with lethal prostate cancer. The Prostate 78 (16) (2018)
Haitao Chen, Rong Na, Vignesh T Packiam, Carly A Conran, Deke Jiang, Sha Tao, Hongjie Yu, Xiaoling Lin, Wei Meng, S Lilly Zheng, Charles B Brendler, Brian T Helfand, Jianfeng Xu
Reclassification of prostate cancer risk using sequentially identified SNPs: Results from the REDUCE trial. The Prostate 77 (11) (2017)
Xiaoling Lin, Zhongzhong Chen, Peng Gao, Zhimei Gao, Haitao Chen, Jun Qi, Fang Liu, Dingwei Ye, Haowen Jiang, Rong Na, Hongjie Yu, Rong Shi, Daru Lu, Siqun Lilly Zheng, Zengnan Mo, Yinghao Sun, Qiang Ding, Jianfeng Xu
TEX15: A DNA repair gene associated with prostate cancer risk in Han Chinese. The Prostate 77 (12) (2017)
Rong Na, Brian T Helfand, Haitao Chen, Carly A Conran, Susan E Crawford, Simon W Hayward, Teuvo L J Tammela, Judy Hoffman-Bolton, Siqun L Zheng, Patrick C Walsh, Johanna Schleutker, Elizabeth A Platz, William B Isaacs, Jianfeng Xu
A genetic variant near GATA3 implicated in inherited susceptibility and etiology of benign prostatic hyperplasia (BPH) and lower urinary tract symptoms (LUTS). The Prostate 77 (11) (2017)
Rong Na, Dingwei Ye, Jun Qi, Fang Liu, Brian T Helfand, Charles B Brendler, Carly A Conran, Vignesh Packiam, Jian Gong, Yishuo Wu, Siqun L Zheng, Zengnan Mo, Qiang Ding, Yinghao Sun, Jianfeng Xu
Prostate health index significantly reduced unnecessary prostate biopsies in patients with PSA 2-10 ng/mL and PSA >10 ng/mL: Results from a Multicenter Study in China. The Prostate 77 (11) (2017)
Haitao Chen, Charles M Ewing, Sigun Zheng, Eli M Grindedaal, Kathleen A Cooney, Kathleen Wiley, Srdjan Djurovic, Ole A Andreassen, Karol Axcrona, Ian G Mills, Jianfeng Xu, Lovise Maehle, Sophie D Fosså, William B Isaacs
Genetic factors influencing prostate cancer risk in Norwegian men. The Prostate 78 (3) (2017)
Danyelle A Winchester, Cathee Till, Phyllis J Goodman, Catherine M Tangen, Regina M Santella, Teresa L Johnson-Pais, Robin J Leach, Jianfeng Xu, S Lilly Zheng, Ian M Thompson, M Scott Lucia, Scott M Lippman, Howard L Parnes, William B Isaacs, Angelo M De Marzo, Charles G Drake, Elizabeth A Platz
Association between variants in genes involved in the immune response and prostate cancer risk in men randomized to the finasteride arm in the Prostate Cancer Prevention Trial. The Prostate 77 (8) (2017)

Jianfeng Xu.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Jianfeng Xu